# COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

> **NCT01596790** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 168 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **OTHER:** Blood analysis by EPISPOT and Cellsearch

## Key facts

- **NCT ID:** NCT01596790
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2020-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596790, "COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01596790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*